HALOBETASOL Drug Patent Profile
✉ Email this page to a colleague
When do Halobetasol patents expire, and when can generic versions of Halobetasol launch?
Halobetasol is a drug marketed by Padagis Israel, Cosette, Fougera Pharms, Sun Pharma Canada, Encube, and Quagen. and is included in fourteen NDAs.
The generic ingredient in HALOBETASOL is halobetasol propionate; tazarotene. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the halobetasol propionate; tazarotene profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Halobetasol
A generic version of HALOBETASOL was approved as halobetasol propionate; tazarotene by SUN PHARMA CANADA on May 2nd, 2025.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for HALOBETASOL?
- What are the global sales for HALOBETASOL?
- What is Average Wholesale Price for HALOBETASOL?
Summary for HALOBETASOL
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 14 |
| Drug Prices: | Drug price information for HALOBETASOL |
| DailyMed Link: | HALOBETASOL at DailyMed |
US Patents and Regulatory Information for HALOBETASOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Padagis Israel | HALOBETASOL PROPIONATE | halobetasol propionate | AEROSOL, FOAM;TOPICAL | 215266-001 | Aug 11, 2023 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Cosette | HALOBETASOL PROPIONATE | halobetasol propionate | OINTMENT;TOPICAL | 077109-001 | Jun 14, 2005 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Padagis Israel | HALOBETASOL PROPIONATE | halobetasol propionate | CREAM;TOPICAL | 077123-001 | Dec 16, 2004 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
